Biotinylated Human DLL3 Domain (352-479) Protein
Catalog No: DLL3-HB004
- Species
- Human
- Expression System
- HEK293
- Tag
- His, Avi
Product overview
Recombinant Biotinylated Human DLL3 Domain (352-479) Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Lys352-Ala479 (UniProt accession: Q9NYJ7-1).
Product Details
- Molecular Aliases
- Delta3; DLL3; Pudgy; SCDO1; SCDO1delta3
- Protein Length
- Lys352-Ala479
- Expression System
- HEK293
- Theoretical Molecular Weight
- The protein has a predicted MW of 17.30 kDa. Due to glycosylation, the protein migrates to 20-25 kDa based on Bis-Tris PAGE result.
- Purity
- > 95% as determined by Bis-Tris PAGE
- Endotoxin
- Less than 1 EU per μg by the LAL method.
- Buffer / Formulation
- Supplied as 0.22 μm filtered solution in PBS, 100mM L-arginine (pH 7.4).
- State
- Liquid
- Storage Conditions
- Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Data Display
Biotinylated Human DLL3 Domain (352-479) on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Background
Delta-like protein 3 (DLL3) is a transmembrane protein that belongs to the Delta/Serrate/Lag-2 (DSL) family of Notch ligands. DLL3 inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm (By similarity).
References
- Saunders L R, Bankovich A J, Anderson W C, et al. A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo[J]. Science Translational Medicine, 2015.
Have questions about this product?
Our technical team can help with product selection, application questions and order support.